These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2573446)

  • 1. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
    Kratz LE; Boughman JA; Needleman BW
    Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
    Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
    J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circumscribed scleroderma: internal manifestations and significant correlation to HLA-DR1 and DR5].
    Luderschmidt C; König G; Leisner B; Scholz S; Albert EE
    Hautarzt; 1985 Sep; 36(9):516-21. PubMed ID: 3877710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
    Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
    J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of HLA antigens with scleroderma].
    Kühnl P; Schütz K; Altmeyer P; Holzmann H; Seidl S
    Z Hautkr; 1985 Jun; 60(11):866-8. PubMed ID: 3892952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis.
    Chauhan B; Santiago L; Hutcheson PS; Schwartz HJ; Spitznagel E; Castro M; Slavin RG; Bellone CJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):723-9. PubMed ID: 11031343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles.
    Murray KJ; Moroldo MB; Donnelly P; Prahalad S; Passo MH; Giannini EH; Glass DN
    Arthritis Rheum; 1999 Sep; 42(9):1843-53. PubMed ID: 10513798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
    J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican mestizo population.
    Vargas-Alarcón G; Granados J; Martínez-Laso J; Gómez-Casado E; Zuñiga J; Salgado N; Hernández-Pacheco G; Hesiquio R; Rodríguez-Reyna TS; Gamboa R; Alcocer-Varela J; Arnaiz-Villena A
    Genes Immun; 2000 Aug; 1(6):367-70. PubMed ID: 11196683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
    Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes.
    Tilanus MG; van Eggermond MC; Fei HM; Schreuder GM; Giphart MJ
    Exp Clin Immunogenet; 1989; 6(2):162-8. PubMed ID: 2576521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
    Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
    Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients.
    Vargas-Alarcón G; Granados J; Ibañez de Kasep G; Alcocer-Varela J; Alarcón-Segovia D
    Clin Exp Rheumatol; 1995; 13(1):11-6. PubMed ID: 7774089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II genotyping of sarcoidosis patients in Hokkaido by PCR-RFLP.
    Ishihara M; Inoko H; Suzuki K; Ono H; Hiraga Y; Ando H; Naruse T; Ishida T; Ohno S
    Jpn J Ophthalmol; 1996; 40(4):540-3. PubMed ID: 9130059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition.
    Pascual M; Nieto A; López-Nevot MA; Ramal L; Matarán L; Caballero A; Alonso A; Martín J; Zanelli E
    Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective.
    Maclaren N; Riley W; Skordis N; Atkinson M; Spillar R; Silverstein J; Klein R; Vadheim C; Rotter J
    Autoimmunity; 1988; 1(3):197-205. PubMed ID: 2979618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA serological and class II genotyping in sarcoidosis patients in Japan.
    Ishihara M; Ishida T; Inoko H; Ando H; Naruse T; Nose Y; Ohno S
    Jpn J Ophthalmol; 1996; 40(1):86-94. PubMed ID: 8739505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.